Commercial Coverage

Oregon’s Drug Decriminalization Creates Unfunded Mandate for Treatment Providers

Oregon's November approval of Measure 110 decriminalizing drug possession represents a landmark shift in criminal justice and addiction policy, redirecting individuals caught with small amounts of controlled substances from...

Amid Growth, Pinnacle CEO Pushes for Methadone MAT Flexibilities

The past several months have been devastating for many behavioral health providers. The COVID-19 pandemic has caused widespread...

How the Pandemic Accelerated Telehealth Adoption

The coronavirus pandemic has reshaped the behavioral health landscape, creating both challenges and opportunities for mental health care...

Virtual Pediatric Behavioral Health Provider Brightline Raises $20 Million

Brightline, a Palo Alto-based startup specializing in virtual pediatric behavioral health care, recently announced a $20 million Series...

Discovery Behavioral Health Expands With Two New Adolescent Mental Health Centers

Discovery Behavioral Health, a portfolio company of Webster Equity Partners, has made another significant move in expanding its...
spot_img

Biden Administration Takes Major Step Forward in Mental Health Parity with New Rule

On March 17, 2025, the Biden administration took a significant step toward improving mental health care in the United States by releasing a final...

The Evolving Investment Landscape in Behavioral Health: What the Future Holds

The behavioral health investment industry has undergone profound changes in the last five years. From the dizzying heights of record-breaking funding to the sharp...

Why Collaborative Care is the Future of Behavioral Health

In the United States, the healthcare system faces a significant challenge: Too many people are not receiving the healthcare they need, and the situation...

Breaking Down Silos: The Future of Integrated Behavioral Health Services

For decades, behavioral health providers have operated in isolated silos, leaving patients to navigate a fragmented and often confusing system of care for substance...

Neuronetics Acquires Greenbrook TMS: A Strategic Acquisition to Strengthen Market Leadership and Drive Long-Term Growth

In a bold move that is set to redefine the landscape of transcranial magnetic stimulation (TMS) therapy, Neuronetics acquisition of Greenbrook TMS marks a...

FDA Rejects MDMA-Assisted Therapy for PTSD: What’s Next for Psychedelic Medicine?

After years of groundbreaking clinical trials and high expectations from both the medical and psychedelic research communities, Lykos Therapeutics has received a disappointing response...
spot_img